Home » Topics » Regulatory » Patents

Patents
RSS

Lilly continues to develop compounds for postmenopausal syndrome

April 2, 1997

Hypoglycemic/hypolipidemic agents from Sankyo

April 1, 1997

Wakunaga discloses angiotensin II antagonists

April 1, 1997

Takeda reports new carbapenems

April 1, 1997

New antitumor agents from Daiichi

April 1, 1997

Antimicrobial agents disclosed by Maruho

April 1, 1997

Terumo claims platelet aggregation/thromboxane synthase inhibitors

April 1, 1997

Antiinflammatory compounds disclosed by Tsumura

April 1, 1997

Terumo describes antiallergic agents

April 1, 1997

Sanofi discloses agents for treating CRF-related disorders

March 27, 1997

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...